下一个

自动播放

Evidence for kinase inhibitor activity in acute myeloid leukaemia

0 意见 • 07/04/23
分享
嵌入
administrator
administrator
订户
0

Visit http://www.ecancer.org for more

Dr Ehninger (University Hospital Dresden, Dresden, Germany) talks to ecancertv at EHA 2015 about the results of a phase II randomised study on the safety and efficacy of sorafenib in leukaemia.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放